Breaking News
September 26, 2018 - Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson’s disease
September 26, 2018 - Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award
September 26, 2018 - New spinout company to tackle drug-resistant infections with novel antibiotics
September 26, 2018 - In depression the brain region for stress control is larger
September 26, 2018 - Smuggling RNA into cells can activate the immune system to fight cancer
September 26, 2018 - Special Focus Issue takes wide view of complementary and integrative medicine in cancer
September 26, 2018 - Researchers now confirm that genome duplication drives evolution of species
September 25, 2018 - Study provides evidence of beta lactamase producing, antimicrobial resistant E. coli in U.S. retail meat
September 25, 2018 - UCI study finds new cause of cerebral microbleeds
September 25, 2018 - Researchers propose mechanism by which ASTN2 protein defects lead to brain disorders
September 25, 2018 - Chinese and German researchers to cooperate more closely in future for better food
September 25, 2018 - Recent study helps predict probability of pregnant mothers to have child with autism
September 25, 2018 - New online, sound matching tool offers tinnitus sufferers potential treatment options
September 25, 2018 - UC Davis researchers take critical step in developing more effective Salmonella vaccine
September 25, 2018 - Antibiotics best paediatric treatment for children’s chronic wet cough
September 25, 2018 - Looking beyond opioids: Stanford pain psychologist briefs Congress
September 25, 2018 - Organs actively fighting back against autoimmune diseases, finds study
September 25, 2018 - Lancaster professor aims to understand how genes affect smoking cessation
September 25, 2018 - Human-oriented perspective needed to better understand Parkinson’s disease
September 25, 2018 - Physical activity may have beneficial effects for people with rare Alzheimer’s disease
September 25, 2018 - FDA Updates on Valsartan Recalls
September 25, 2018 - 3-D-printed tracheal splints used in groundbreaking pediatric surgery
September 25, 2018 - Who is the designated driver, or proxy, for your health decisions?
September 25, 2018 - New chemo-optogenetic method enables multi-directional activity control of cellular processes
September 25, 2018 - Study explores link between genetic predisposition to Alzheimer’s and cardiometabolic risk factors
September 25, 2018 - NeoTract presents new clinical data from studies of UroLift System for patients with BPH
September 25, 2018 - Statins Improve Long-Term Survival After AAA Repair
September 25, 2018 - Novel brain network linked to chronic pain in Parkinson’s disease
September 25, 2018 - Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear
September 25, 2018 - Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations
September 25, 2018 - FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials
September 25, 2018 - IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities
September 25, 2018 - Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results
September 25, 2018 - How to Protect Your Eyesight
September 25, 2018 - Novel approach allows researchers to define how cells in the retina respond to diabetes
September 25, 2018 - Columbia University announces winners of 2018 Louisa Gross Horwitz Prize
September 25, 2018 - New model enables anyone to run powerful simulations, complex calculations easily
September 25, 2018 - Clinical trial investigators found non-compliant with requirement to report results on EU register
September 25, 2018 - Study analyzes quality of protein supplements in function of source, treatment and storage
September 25, 2018 - FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome
September 25, 2018 - U.S. Alzheimer’s Cases to Nearly Triple by 2060
September 25, 2018 - Improving cell replacement therapy for Parkinson’s disease
September 25, 2018 - Genervon reports new findings that drug candidate GM6 attenuates Alzheimer’s disease in mice model
September 25, 2018 - FDA approves new 5 mm diameter drug-eluting stent from Cook Medical
September 25, 2018 - New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks
September 25, 2018 - Researchers analyze response to combination immunotherapy for patients with rare skin cancer
September 25, 2018 - Study sheds light on how brain protein may be involved neurodevelopmental disorders
September 25, 2018 - Where to draw the line on incentives
September 25, 2018 - Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases
September 25, 2018 - ‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms
September 25, 2018 - Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE
September 25, 2018 - Global leaders must make bold commitments at first-ever UN tuberculosis summit
September 25, 2018 - Brief sleep intervention works long-term to prevent child obesity
September 25, 2018 - Vaping among kids and teens a growing concern
September 25, 2018 - Public launch of products and application solutions from Porvair Laboratory Division
September 25, 2018 - Harmful H. pylori may play a role in Parkinson’s disease
September 25, 2018 - Researchers develop way to measure different types of fear of falling in patients with Parkinson’s
September 25, 2018 - Fracture causes bone density losses throughout the body
September 25, 2018 - Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder
September 25, 2018 - Hybrid theranostic complex shows high therapeutic efficacy against tumor cells
September 25, 2018 - FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
September 25, 2018 - Toxicological evaluation and dosimetry estimation of potential PET radiotracer
September 25, 2018 - 5 obstacles parents commonly face in child obesity treatment and how to overcome them
September 25, 2018 - Immunologist to study how Chikungunya causes devastating effects in older adults
September 25, 2018 - Rural borderland communities vulnerable to high stress impacting mental and physical health
September 25, 2018 - SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship
September 25, 2018 - Common painkiller not effective in controlling chronic pain after traumatic nerve injury
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
D.C. Week: States Plead for Federal $$ in Opioid Fight

D.C. Week: States Plead for Federal $$ in Opioid Fight

image_pdfDownload PDFimage_print

WASHINGTON — Republican and Democratic governors don’t agree on much in the healthcare space but when it comes to opioids there is consensus: Real dollars are needed.

Governors Ask Congress for More $$$ for Opioid Epidemic

Governors pressed senators for more funding to help tackle the opioid epidemic, as well as flexibility for states in tailoring spending to suit their specific needs, during a hearing of the Senate Health, Education, Labor and Pensions (HELP) Committee on Thursday.

Gov. Larry Hogan (R-Md.) thanked Congress for the $6 billion secured in its budget agreement to fight the opioid and heroin crisis, but “it’s a drop in the bucket compared to what we actually need,” he said.

Maryland, a small state, has already spent $500 million to battle the opioid epidemic alone, he continued.

“Six billion stretched across the country is not going to go very far … It’s the long-term recovery support services that we’re going to need a way to pay for.”

HHS Chief Wants to Lighten Data Collection Burdens

In an ideal world, providers would be able to spend less time collecting quality data and more time actually improving the quality of care, Health and Human Services (HHS) Secretary Alex Azar said here Thursday.

“We need to ensure that in the quest for information on quality, we don’t have providers, payers, or others spend so much time accumulating data to improve reporting that they’re not actually improving quality,” Azar said during a press briefing with reporters at HHS headquarters.

“Let’s make sure it’s the information that really matters; let’s have the minimal necessary reporting burden to get the job done to ensure we’re providing actionable information for decision-makers for quality, price, and value. There have been so many [reporting] burdens, especially for solo practitioners … If needed, so be it, but let’s make sure it serves the purpose.”

CMS Aims to Give Patients Access to Health Records

The Trump administration launched a program Tuesday aimed at giving patients more control over their own healthcare records.

The initiative, called MyHealthEData, “will help to break down the barriers that prevent patients from having electronic access and true control of their own health records from the device or application of their choice,” the Centers for Medicare & Medicaid Services (CMS) said in a press release. “Patients will be able to choose the provider that best meets their needs and then give that provider secure access to their data, leading to greater competition and reducing costs.”

Patients deserve to receive an electronic copy of their health record and to “be able to share their data with whomever they want, making the patient the center of the healthcare system,” the release continued. “Patients can use their information to actively seek out providers and services that meet their unique healthcare needs, have a better understanding of their overall health, prevent disease, and make more informed decisions about their care.”

As part of the initiative, CMS Administrator Seema Verma also on Tuesday announced a Medicare patient records initiative known as Blue Button 2.0. In her prepared remarks, Verma said that although Medicare patients have for a long time had the ability to download their health information from the CMS Blue Button site, what they got was in the form of an Excel spreadsheet or a PDF file, “without any context or help in understanding what the data is telling them.”

Novel HIV Drug OK’d

A first-in-class agent for HIV infection targeting the CD4 protein ibalizumab-uiyk (Trogarzo), won FDA approval Tuesday, the agency announced.

The intravenous biologic drug is indicated for adults with multidrug-resistant HIV infection who have previously failed to respond to other agents.

In binding to the CD4 molecule on T cells, ibalizumab helps prevent HIV from entering the cells. It’s the first monoclonal antibody for treating HIV infection to win FDA approval, and the first to target CD4-mediated viral entry.

Approval was based primarily on a 40-patient trial in heavily pretreated HIV-infected individuals. Some 43% of patients achieved undetectable viral load when ibalizumab was given with at least one other active drug. About half achieved viral loads less than 200 copies per mL.

Gottlieb Pushes for Biosimilars

Insurers and others can help educate practitioners about biosimilar medications and share rebate drug cost savings with consumers, to improve access and adherence to innovative biologic drugs, FDA Commissioner Scott Gottlieb, MD, said here Wednesday.

Addressing the annual policy conference sponsored by America’s Health Insurance Plans, the chief trade group for private insurers, Gottlieb spoke for nearly 30 minutes, primarily about the obstacles preventing more affordable biosimilars from getting into patients’ hands; he faulted insurers and drug manufacturers alike.

“Patient access to these innovations will depend on reforms,” Gottlieb said, encouraging parties in American healthcare “to deliver the best medical outcomes … doing this with the long run in mind and patients at the heart of what we do.”

Initiative Aims to Help Veterans with Mental Illness

A private veterans’ group is joining with the Department of Veterans Affairs (VA) to try to help mentally ill veterans who have fallen through the cracks in the system.

“We all hear about 20 [veterans] a day that take their own life … or [those who] become incarcerated without first receiving the support and treatment they need, which should include mental health services,” Lana McKenzie, RN, chief medical executive of AMVETS (American Veterans), a group that represents the interests of 20 million veterans, said at a press briefing here Tuesday. “Today we’re here to change that.”

The multi-pronged initiative, called Healthcare Evaluation, Advocacy, and Legislation (HEAL), involves reaching out to veterans through a series of town halls, round tables, and other public forums. AMVETS is hiring case managers to work with the veterans and get them connected to healthcare services inside or outside of the VA, whichever is appropriate. The organization is also launching a hotline, 833-VET-HEAL, on March 19th for veterans to reach out for help that way. AMVETS will work with the VA to coordinate services for the veterans they help through the initiative.

Next Week

On Tuesday, the American Enterprise Institute will discuss the “numbers behind the opioid crisis.”

On Wednesday, the Senate Committee on Indian Affairs will discuss opioids.

On Thursday, the Senate HELP Committee will explore differing views on the 340B drug program.

And the House Committee on Appropriations will hold a FY2019 Budget Hearing concerning HHS.

2018-03-10T12:00:00-0500

Tagged with:

About author

Related Articles